The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice

Kidney International

Volumn 57, Issue 2, 2000, Pages 570-577

  Hunley, Tracy E ^a   Tamura, Masaaki ^a   Stoneking, Bradley J ^a   Nishimura, Hideki ^a   Ichiki, Toshihiro ^a   Inagami, Tadashi ^a   Kon, Valentina ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ACE inhibition; AT2 receptor; Bradykinin; Progressive renal disease; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; KIDNEY; KNOCKOUT MOUSE; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TESTIS;

EID: 0033935114     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00877.x     Document Type: Article

References (51)

1. 1. HELIN K, STOLL M, MEFFERI S, STROTH U, UNGER T: The role of angiotensin receptors in cardiovascular diseases. Ann Med 29:23-29, 1997
2. 2. KLAHR S, MORRISSEY J: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176, 1998
3. 3. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
4. 4. VAUGHAN DE, PFEFFER MA: Angiotensin-converting enzyme inhibitors and cardiovascular remodeling. Cardiovasc Res 28:159-165, 1994
5. 5. PFEFFER MA, BRAUNWALD E, MOYE LA, BASTA L, BROWN EJ JR, CUDDY TE, DAVIS BR, GELTMAN EM, GOLDMAN S, FLAKER GC, KLEIN M, LAMAS GA, PACKER M, ROULEAU J, ROULEAU JL, RUTHERFORD J, WERTHEIMER JH, HAWKINS CM: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. N Engl J Med 327:669-677, 1992
6. 6. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE: RD: The effect of angiotensin-converting enzyme inhibitor on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
7. 7. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JF, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The angiotensin-converting enzyme inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
8. 8. RIGAI B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
9. 9. FISHEL RS, EISENBERG S, SHAI SY, REDDEN RA, BERNSTEIN KE, BERK BC: Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 25:343-349, 1995
10. 10. FISHEL RS, THOURANI V, EISENBERG SJ, SHAI SY, CORSON MA, NABEL EG, BERNSTEIN KE, BERK BC: Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. J Clin Invest 95:377-387, 1995
11. 11. KAWAGUCHI H, SAWA H, YASUDA H: Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J Mol Cell Cardiol 22:839-842, 1990
12. 12. KING SJ, BOOYSE FM, LIN P, TRAYLOR M, NARRATES AJ, OPARIL S: Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis. Am J Physiol 256:C1231-C1238, 1989
13. 13. DIEI F, PRATT RE, BERRY GJ, MOMOSE N, GIBBONS GH, DZAU VJ: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767, 1996
14. 14. SCHUNKERT H, JACKSON B, TANG SS, SCHOEN FJ, SMITS JFM, APSTEIN CS, LORELL BH: Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 87:1328-1339, 1993
15. 15. RAKUGI H, KIM D-K, KRIEGER JE, WANG DS, DZAU VJ, PRATT RE: Induction of angiotensin converting enzyme in the neointima after vascular injury: Possible role in restenosis. J Clin Invest 93:339-346, 1994
16. 16. MORISHITA R, GIBBONS GH, ELLISON KE, LEE W, ZHANG L, YU H, KANEDA Y, OGIHARA T, DZAU VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy: In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94:978-984, 1994
17. 17. MA J, NISHIMURA H, FOGO A, KON V, INAGAMI T, ICHIKAWA I: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53:937-944, 1998
18. 18. STONEKING BJTE, HUNLEY H, NISHIMURA J, MA A, FOGO T, INAGAMI M, TAMURA MA, ADAMS JW, BROCK III, KON V: Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J Urol 160:1070-1074, 1998
19. 19. ICHIKI T, LABOSKY PA, SHIOTA C, OKUYAMA S, IMAGAWA Y, FOGO A, NIIMURA F, ICHIKAWA I, HOGAN BLM, INAGAMI T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-750, 1995
20. 20. STOLL M, STECKELINGS UM, PAUL M, BOTTARI SP, METZGER R, UNGER T: The angiotensin II AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651-657, 1995
21. 21. YAMADA T, HORIUCHI M, DZAU VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93:156-160, 1996
22. 22. NAKAJIMA M, HUTCHINSON HG, FUJINAGA M, HAYASHIDA W, MORISHITA R, ZHANG L, HORIUCHI M, PRATT RE, DZAU VJ: The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663-10667, 1995
23. 23. OHKUBO N, MATSUBARA H, NOZAWA Y, MORI Y, MURASAWA S, KIJIMA K, MARUYAMA K, MASAKI H, TSUTUMI Y, SHIBAZAKI Y, IWASAKA T, INADA M: Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 96:3954-3962, 1997
24. 24. RAKUGI H, WANG DS, DZAU VJ, PRATT RE: Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 90:449-455, 1994
25. 25. SCHIEFFER B, WIRGER A, MEYBRUNN M, SEITZ S, HOLTZ J, RIEDE UN, DREXLER H: Comparative effects of chronic ACE inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89:2273-2282, 1994
26. 26. SAWARD L, ZAHRADKA P: The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol 28:499-506, 1996
27. 27. FEENER EP, NORTHRUP JM, ATELLO LP, KING GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular smooth muscle cells. J Clin Invest 95:1353-1362, 1995
28. 28. TAKAHASI K. BARDHAN S, KAMBAYASHI Y, SHIRAI H, INAGAMI T: Protein tyrosine phosphatase inhibition by angiotensin II in rat pheo-chromocytoma cells through type 2 receptor, AT2. Biochem Biophys Res Commun 198:60-66, 1994
29. 29. LO M, LIU K-L, LANTELME P, SASSARD J: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 95:1394-1397, 1995
30. 30. SIRAGY HM, CAREY RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100:264-269, 1997
31. 31. TIAN B, MENG QC, CHEN Y-F, KREGE JH, SMITHIES O, OPARIL S: Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension 30:128-133, 1997
32. 32. MENG QC, BALCELLS E, DELL 'ITALIA LJ, DURAND J, OPARIL S: Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem Pharmacol 50:1445-1450, 1995
33. 33. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
34. 34. BERNSTEIN KE, MARTIN BM, BERNSTEIN EA, LINTON J, STRIKER L, STRIKER G: The isolation of angiotensin-converting enzyme cDNA. J Biol Chem 263:11021-11024, 1988
35. 35. DANIELSON PE, FORSS-PETTER S, BROW MA, CALVETTA L, DOUGLASS J, MILNER RJ, SUTCLIFFE JG: p1B15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267, 1988
36. 36. RAMCHANDRAN R, SEN GC, MISONO K, SEN I: Regulated cleavage secretion of the membrane-bound angiotensin-converting enzyme. J Biol Chem 269:2125-2130, 1994
37. 37. BELDENT V, MICHAUD A, WEI L, CHAUVET M-T, CORVOL P: Proteolytic release of human angiotensin-converting enzyme: Localization of the cleavage site. J Biol Chem 268:26428-26434, 1993
38. 38. DELL 'ITALIA LJQC, MENG E, BALCELLS C-C, WEI R, PALMER GR, HAGEMAN J, DURAND GH, HANKES, OPARIL S: Compartmentalization of angiotensin II generation in the dog heart: Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 100:253-258, 1997
39. 39. MASAKI H, KURIHARA T, YAMAKI A, INOMATA N, NOZAWA Y, MORI Y, MURASAWA S, KlZIMA K, MARUYAMA K, HORIUCHI M, DZAU VJ, TAKAHASHI H, IWASAKA T, INADA M, MATSUBARA H: Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 101:527-535, 1998
40. 40. WEINBERG EO, LEE MA, WEIGNER M, LINDPAINTNER K, BISHOP SP, BENEDICT CR, HO KKL, DOUGLAS PS, CHAFIZADEH E, LORELL BH: Angiotensin AT1 receptor inhibition: Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 95:1592-1600, 1997
41. 41. LIU Y-H, YANG X-P, SHAROV VG, NASS O, SABBAH HN, PETERSON E, CARRETERO OA: Effects of angiotensin-converting enzyme inhibitors and angiotensin type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors. J Clin Invest 99:1926-1935, 1997
42. 42. SCHUNKERT H, HENSE H-W, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
43. 43. HUNLEY TE, JULIAN BA, PHILLIPS JA III, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
44. 44. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
45. 45. EHLERS MRW, FOX EA, STRYDOM DJ, RIORDAN JF: Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86:7741-7745, 1989
46. 46. HOWARD TE, SHAI S-Y, LANGFORD KG, MARTIN BM, BERNSTEIN KE: Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol 10:4294-4302, 1990
47. 47. DANSER AHJ, SCHALEKAMP MADH, BAX WA, VAN DEN BRINK AM, SAXENA PR, RIEGGER GAJ, SCHUNKERT H: Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
48. 48. WILLIAMS TA, VILLARD E, PRIGENT Y, DADOUNE J-P, SOUBRIER F: A genetic study of angiotensin I-converting enzyme levels in human semen. Mol Cell Endocrinol 107:215-219, 1995
49. 49. SMITHIES O: Theodore Cooper memorial lecture: A mouse view of hypertension. Hypertension 30:1318-1324, 1997
50. 50. KREGE JH, KIM H-S, MOYER JS, JENNETTE JC, PENG L, HILLER SK, SMITHIES O: Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29(Pt 2):150-157, 1997
51. 51. BROWN NJ, BLAIS C JR, GANDHI SK, ADAM A: ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 32:373-377, 1998